Nuo Therapeutics, Inc. (AURX) — Cost of Revenue
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $1.10M | +261.8% |
| 2024 | $302.8K | +140.2% |
| 2023 | $126.1K | +556.3% |
| 2022 | $19.2K | — |
| 2021 | $0 | — |
| 2020 | $0 | -100.0% |
| 2019 | $114.6K | -29.7% |
| 2018 | $163.0K | -85.1% |
| 2017 | $1.09M | — |
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $1.10M | +261.8% |
| 2024 | $302.8K | +140.2% |
| 2023 | $126.1K | +556.3% |
| 2022 | $19.2K | — |
| 2021 | $0 | — |
| 2020 | $0 | -100.0% |
| 2019 | $114.6K | -29.7% |
| 2018 | $163.0K | -85.1% |
| 2017 | $1.09M | — |